Patents by Inventor Marc S. Tesconi

Marc S. Tesconi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES
    Publication number: 20140303182
    Abstract: A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R1-R9 and R12-R14 are as defined herein
    Type: Application
    Filed: March 17, 2014
    Publication date: October 9, 2014
    Applicant: NOVARTIS AG
    Inventors: Shaopei Cai, Joyce Chou, Eric Harwood, Timothy Machajewski, David Ryckman, Xiao Shang, Shuguang Zhu, Augustus Okhamate, Marc S. Tesconi
  • Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
    Publication number: 20130338171
    Abstract: A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R1-R9 and R12-R14 are as defined herein
    Type: Application
    Filed: August 1, 2013
    Publication date: December 19, 2013
    Applicant: Novartis AG
    Inventors: Shaopei Cai, Joyce Chou, Eric Harwood, Timothy Machajewski, David Ryckman, Xiao Shang, Shuguang Zhu, Augustus Okhamafe, Marc S. Tesconi
  • PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES
    Publication number: 20130018058
    Abstract: A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R1-R9 and R12-R14 are as defined herein
    Type: Application
    Filed: December 2, 2011
    Publication date: January 17, 2013
    Inventors: Shaopei Cai, Joyce Chou, Eric Harwood, Timothy Machajewski, David Ryckman, Xiao Shang, Shuguang Zhu, Augustus O. Okhamafe, Marc S. Tesconi
  • METHODS FOR SYNTHESIZING QUINOLINONE COMPOUNDS
    Publication number: 20120277434
    Abstract: A method of synthesizing a substituted or unsubstituted 4-amino-3-benzimidazolyl quinolinone compound includes reacting a first compound having the formula I with a second compound having the formula II in a suitable solvent in the presence of a sodium or potassium salt of a base.
    Type: Application
    Filed: July 2, 2012
    Publication date: November 1, 2012
    Inventors: Shaopei Cai, Joyce Chou, Eric Harwood, Timothy MacHajewski, David Ryckman, Xiao Shang, Shuguang Zhu, Augustus O. Okhamafe, Marc S. Tesconi
  • CRYSTAL FORMS OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
    Publication number: 20100113541
    Abstract: The present invention is directed to monohydrate and anhydrate crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol, an estrogenic receptor modulator useful in the treatment of, for example, diseases related to abnormal levels of estrogen.
    Type: Application
    Filed: December 18, 2009
    Publication date: May 6, 2010
    Applicant: Wyeth LLC
    Inventors: Abdolsamad TADAYON, Silvio IERA, Hong WEN, Marc S. TESCONI, Mannching Sherry KU
  • Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
    Patent number: 7683182
    Abstract: The present invention is directed to monohydrate and anhydrate crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol, an estrogenic receptor modulator useful in the treatment of, for example, diseases related to abnormal levels of estrogen.
    Type: Grant
    Filed: March 6, 2006
    Date of Patent: March 23, 2010
    Assignee: Wyeth LLC
    Inventors: Abdolsamad Tadayon, Silvio Iera, Hong Wen, Marc S. Tesconi, Mannching Sherry Ku
  • PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES
    Publication number: 20090181979
    Abstract: A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R1-R9 and R12-R14 are as defined herein
    Type: Application
    Filed: March 4, 2009
    Publication date: July 16, 2009
    Inventors: Shaopei Cai, Joyce Chou, Eric Harwood, Timothy Machajewski, David Ryckman, Xiao Shang, Shuguang Zhu, Augustus O. Okhamafe, Marc S. Tesconi
  • Aqueous Pharmaceutical Formulations of ER-beta Selective Ligands
    Publication number: 20070191442
    Abstract: The present invention relates to aqueous formulations of ER? selective ligands. In some embodiments, the formulations include an ER? selective ligand, a solubilizer/complexant component, and a pH adjusting component. The invention further provides preparations of the formulations, and uses thereof.
    Type: Application
    Filed: February 13, 2007
    Publication date: August 16, 2007
    Inventors: MARC S. TESCONI, MANNCHING SHERRY KU